Bentley has worked with GlaxoSmithKline, Roche, as well as with CROs and the service sector.

Prior to joining Novella, Bentley worked with i3 as the senior therapeutic director for Oncology (Europe, Middle East and Africa).

Her experience in oncology is in line with Novella’s corporate growth strategies, which include recent acquisitions of Prologue Research and OSI’s Boulder office.

Novella Clinical European operations managing director Nigel Trim said that Jane has successfully led teams across Europe and the Middle East Region, as well as global programmes in oncology and provides a level of expertise and knowledge that really facilitates programme development.

Bentley said that she is delighted to be joining the team and to utilise her background in operations management and business development in an exciting new direction and to support the future growth of the Global business for Novella.